SALT
LAKE CITY, May 6, 2022 /PRNewswire/ -- PolarityTE,
Inc. (Nasdaq: PTE) today announced that it will report results
for the three-month period ended March 31,
2022, by press release on Monday, May
16, 2022, at approximately 7:30 a.m.
Eastern Time.
In addition, the Company will host a conference call and webcast
with Q&A on May 16, 2022, at
8:30 a.m. Eastern Time. The
conference call can be accessed by calling 1-800-289-0459 with
passcode 399675 and referencing "PolarityTE First Quarter 2022
Business Update". A webcast of the conference call can be
accessed by using the link below.
Earnings Call Webcast - CLICK HERE
A replay of the earnings conference call will be available for
30 days, beginning approximately one hour after the conclusion of
the call and can be found by visiting PolarityTE's website at
https://www.polarityte.com/news-media/events, or by clicking on the
link above.
About PolarityTE®
PolarityTE, Inc., headquartered in
Salt Lake City, Utah, is a
biotechnology company developing regenerative tissue
products. PolarityTE's first regenerative tissue product is
SkinTE®. PolarityTE has an open investigational new drug
application (IND) for SkinTE® with the U.S. Food and Drug
Administration (FDA) and is now pursuing the first of two pivotal
studies on SkinTE® needed to support a biologics license
application (BLA) for a chronic cutaneous ulcer indication.
SkinTE® is available for investigational use only. Learn more at
www.PolarityTE.com.
POLARITYTE, the POLARITYTE logo, SKINTE, and WHERE SELF
REGENERATES SELF are registered trademarks of PolarityTE, Inc.
CONTACTS
Investors:
PolarityTE Investor Relations
ir@PolarityTE.com
(385) 831-5284
Media:
David Schull or
Ignacio Guerrero-Ros
David.schull@russopartnersllc.com
Ignacio.guerrero-ros@russopartnersllc.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/polarityte-to-report-q1-2021-financial-results-on-may-16-2022-301541444.html
SOURCE PolarityTE, Inc.